p27, cyclin E, and CDK2 expression in normal and cancerous endometrium

Area of Science:

• Gynecologic Oncology
• Molecular Biology
• Cell Cycle Regulation

Background:

• Endometrial cancer is a common gynecologic malignancy.
• Cell cycle regulators like p27, cyclin E, and CDK2 play crucial roles in cell proliferation and cancer development.
• Understanding their expression patterns in normal and cancerous endometrium across menopausal status is vital for elucidating disease mechanisms.

Purpose of the Study:

• To investigate the immunohistochemical expression of p27, cyclin E, and CDK2 in normal and cancerous endometrial tissues.
• To correlate these expressions with menopausal status and disease development.

Main Methods:

• Immunohistochemistry was used to assess the expression of p27, cyclin E, and CDK2.
• Western blot analysis and semi-quantitative PCR were employed to confirm protein and mRNA levels.
• Telomerase activity was also evaluated.

Main Results:

• p27 expression was significantly higher in premenopausal normal endometrium than postmenopausal normal endometrium and significantly lower in endometrial cancer from premenopausal women.
• Cyclin E expression was significantly higher in premenopausal normal endometrium than postmenopausal normal endometrium and significantly higher in endometrial cancer from postmenopausal women.
• No significant difference in CDK2 staining was observed between normal and cancerous endometrium, but a positive correlation between cyclin E and CDK2 was found in cancers.

Conclusions:

• Decreased p27 expression, potentially due to post-translational modifications, may contribute to endometrial cancer development in premenopausal women.
• Increased cyclin E expression might play a role in endometrial cancer development in postmenopausal women.
• These distinct molecular profiles suggest different pathways in endometrial carcinogenesis based on menopausal status.